ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection
Hye Won Hwang, Sang Yun Ha, Heejin Bang, Cheol-Keun Park
Cancer Res Treat. 2015;47(4):853-861.   Published online 2015 Feb 16     DOI: https://doi.org/10.4143/crt.2014.177
Citations to this article as recorded by Crossref logo
Comprehensive Analyses and Experiments Confirmed IGFBP5 as a Prognostic Predictor Based on an Aging-genomic Landscape Analysis of Ovarian Cancer
Ting-Yu Fan, Li-li Xu, Hong-Feng Zhang, Juan Peng, Dan Liu, Wen-Da Zou, Wen-Jie Feng, Mei Qin, Juan Zhang, Hui Li, Yu-Kun Li
Current Cancer Drug Targets.2024; 24(7): 760.     CrossRef
Tumor-Promoting ATAD2 and Its Preclinical Challenges
Haicheng Liu, Qianghai Wen, Sheng Yan, Weikun Zeng, Yuhua Zou, Quanliang Liu, Guoxi Zhang, Junrong Zou, Xiaofeng Zou
Biomolecules.2022; 12(8): 1040.     CrossRef
Metabolism-Related Gene Pairs to Predict the Clinical Outcome and Molecular Characteristics of Early Hepatocellular Carcinoma
Junling Wu, Zeman Lin, Daihan Ji, Zhenli Li, Huarong Zhang, Shuting Lu, Shenglin Wang, Xiaolong Liu, Lu Ao
Cancers.2022; 14(16): 3957.     CrossRef
ATAD2 Upregulation Promotes Tumor Growth and Angiogenesis in Endometrial Cancer and Is Associated with Its Immune Infiltration
Can Wang, Yue Yin, Zhenxing Sun, Yiru Wang, Fei Li, Yan Wang, Zexue Zhang, Xiuwei Chen, Luca Falzone
Disease Markers.2022; 2022: 1.     CrossRef
Elevated serum alpha-fetoprotein levels are associated with poor prognosis of hepatocellular carcinoma after surgical resection: A systematic review and meta-analysis
Hong-Lin Chen, Yu-Hua Chen, Lin Du, Yi-Ping Song, Bin Zhu
Arab Journal of Gastroenterology.2021; 22(1): 12.     CrossRef
Emerging oncogene ATAD2: Signaling cascades and therapeutic initiatives
Aditi Nayak, Madhuri Dutta, Anasuya Roychowdhury
Life Sciences.2021; 276: 119322.     CrossRef
ATAD2 interacts with C/EBPβ to promote esophageal squamous cell carcinoma metastasis via TGF-β1/Smad3 signaling
Lian-Jing Cao, Yi-Jun Zhang, Si-Qi Dong, Xi-Zhao Li, Xia-Ting Tong, Dong Chen, Zi-Yi Wu, Xiao-Hui Zheng, Wen-Qiong Xue, Wei-Hua Jia, Jiang-Bo Zhang
Journal of Experimental & Clinical Cancer Research.2021;[Epub]     CrossRef
Evaluation of ATAD2 as a Potential Target in Hepatocellular Carcinoma
Umut Ekin, Haluk Yuzugullu, Cigdem Ozen, Peyda Korhan, Ezgi Bagirsakci, Funda Yilmaz, Ozge Gursoy Yuzugullu, Hamdiye Uzuner, Hani Alotaibi, Petek Ballar Kirmizibayrak, Nese Atabey, Gökhan Karakülah, Mehmet Ozturk
Journal of Gastrointestinal Cancer.2021; 52(4): 1356.     CrossRef
Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway
Nuo Li, Yang Yu, Baoming Wang
American Journal of Physiology-Cell Physiology.2020; 319(1): C93.     CrossRef
Integrated Bioinformatics Analysis of the Clinical Value and Biological Function of ATAD2 in Hepatocellular Carcinoma
Xiangyu Meng, Lu Wang, Bo Zhu, Jun Zhang, Shuai Guo, Qiang Li, Tao Zhang, Zhichao Zheng, Gang Wu, Yan Zhao
BioMed Research International.2020; 2020: 1.     CrossRef
Hitting a Moving Target: Simulation and Crystallography Study of ATAD2 Bromodomain Blockers
Aymeric Dolbois, Laurent Batiste, Lars Wiedmer, Jing Dong, Manuela Brütsch, Danzhi Huang, Nicholas M. Deerain, Dimitrios Spiliotopoulos, Iván Cheng-Sánchez, Eleen Laul, Cristina Nevado, Paweł Śledź, Amedeo Caflisch
ACS Medicinal Chemistry Letters.2020; 11(8): 1573.     CrossRef
Fibrolamellar hepatocellular carcinoma: Case report
Ivan I. Shtefanov, Darkhan N. Akhmedin, Assiya M. Kukanova, Ainagul A. Zhakipova, Abai K. Makishev
Polish Annals of Medicine.2020;[Epub]     CrossRef
Structural Insights into the Recognition of Mono- and Diacetylated Histones by the ATAD2B Bromodomain
Jonathan T. Lloyd, Kyle McLaughlin, Mulu Y. Lubula, Jamie C. Gay, Andrea Dest, Cong Gao, Margaret Phillips, Marco Tonelli, Gabriel Cornilescu, Matthew R. Marunde, Chiara M. Evans, Samuel P. Boyson, Samuel Carlson, Michael-Christopher Keogh, John L. Markle
Journal of Medicinal Chemistry.2020; 63(21): 12799.     CrossRef
Disulfide bridge formation influences ligand recognition by the ATAD2 bromodomain
Jamie C. Gay, Brian E. Eckenroth, Chiara M. Evans, Cassiano Langini, Samuel Carlson, Jonathan T. Lloyd, Amedeo Caflisch, Karen C. Glass
Proteins: Structure, Function, and Bioinformatics.2019; 87(2): 157.     CrossRef
Overexpression of microRNA‐186 inhibits angiogenesis in retinoblastoma via the Hedgehog signaling pathway by targeting ATAD2
Shuai Wu, Mei Han, Chao Zhang
Journal of Cellular Physiology.2019; 234(10): 19059.     CrossRef
A Humanized Yeast Phenomic Model of Deoxycytidine Kinase to Predict Genetic Buffering of Nucleoside Analog Cytotoxicity
Santos, Icyuz, Pound, William, Guo, McKinney, Niederweis, Rodgers, IV
Genes.2019; 10(10): 770.     CrossRef
Prognostic value of ATPase family, AAA+ domain containing 2 expression in human cancers
Hua-Jing Han, Qian-Yi Huang, Li-Jun Huang, Fan Chang, Qi-Zhi Diao
Medicine.2019; 98(39): e17180.     CrossRef
The clinical significance of lipopolysaccharide binding protein in hepatocellular carcinoma
Quan‑Yu Cai, Jing‑Hua Jiang, Ri‑Ming Jin, Guang‑Zhi Jin, Ning‑Yang Jia
Oncology Letters.2019;[Epub]     CrossRef
ATAD2 is associated with malignant characteristics of pancreatic cancer cells
Nairong Liu, Kohei Funasaka, Tomohiko Obayashi, Ryoji Miyahara, Yoshiki Hirooka, Hidemi Goto, Takeshi Senga
Oncology Letters.2019;[Epub]     CrossRef
Bromodomain-containing proteins in prostate cancer
Alfonso Urbanucci, Ian G. Mills
Molecular and Cellular Endocrinology.2018; 462: 31.     CrossRef
Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach
Duncan C. Miller, Mathew P. Martin, Santosh Adhikari, Alfie Brennan, Jane A. Endicott, Bernard T. Golding, Ian R. Hardcastle, Amy Heptinstall, Stephen Hobson, Claire Jennings, Lauren Molyneux, Yvonne Ng, Stephen R. Wedge, Martin E. M. Noble, Celine Cano
Organic & Biomolecular Chemistry.2018; 16(11): 1843.     CrossRef
A Panel of Genes Identified as Targets for 8q24.13-24.3 Gain Contributing to Unfavorable Overall Survival in Patients with Hepatocellular Carcinoma
Kun Zhao, Yu Zhao, Jia-yi Zhu, Hui Dong, Wen-ming Cong, Yi Yu, Hui Wang, Zhong-Zheng Zhu, Qing Xu
Current Medical Science.2018; 38(4): 590.     CrossRef
Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery
Xiao-Yu Yang, Bin Wu, Sen-Lin Ma, Lei Yin, Meng-Chao Wu, Ai-Jun Li
Technology in Cancer Research & Treatment.2018; 17: 153303381879419.     CrossRef
MicroRNA-372 functions as a tumor suppressor in cell invasion, migration and epithelial-mesenchymal transition by targeting ATAD2 in renal cell carcinoma
Shiqi Ji, Xiaolin Su, Haijian Zhang, Zhixing Han, Yuqian Zhao, Qingjun Liu
Oncology Letters.2018;[Epub]     CrossRef
The role of miR-372 in ovarian carcinoma cell proliferation
Xue Guan, Zhi-Hong Zong, Shuo Chen, Xiu-Bo Sang, Dan-dan Wu, Li-li Wang, Yao Liu, Yang Zhao
Gene.2017; 624: 14.     CrossRef
ATAD2 overexpression is associated with progression and prognosis in colorectal cancer
Mingming Hou, Rui Huang, Yanni Song, Di Feng, Yang Jiang, Ming Liu
Japanese Journal of Clinical Oncology.2016; 46(3): 222.     CrossRef
Clinical and Prognostic Significance of ANCCA in Squamous Cell Lung Carcinoma Patients
Dingmiao Wang, Yang Pan, Ting Hao, Yong Chen, Shiming Qiu, Ling Chen, Jinping Zhao
Archives of Medical Research.2016; 47(2): 89.     CrossRef
ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker
M.- J. Zhang, C.- Z. Zhang, W.- J. Du, X.- Z. Yang, Z.- P. Chen
Clinical and Translational Oncology.2016; 18(8): 776.     CrossRef
Low expression of DCXR protein indicates a poor prognosis for hepatocellular carcinoma patients
Xiaofeng Hang, Zhiqin Wu, Kaijian Chu, Guanzhen Yu, Haoran Peng, Haiguang Xin, Xiaohui Miao, Junxue Wang, Wensheng Xu
Tumor Biology.2016; 37(11): 15079.     CrossRef
ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication
Seong Joo Koo, Amaury E. Fernández-Montalván, Volker Badock, Christopher J. Ott, Simon J. Holton, Oliver von Ahsen, Joern Toedling, Sarah Vittori, James E. Bradner, Mátyás Gorjánácz
Oncotarget.2016; 7(43): 70323.     CrossRef
Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling
Wen-Jing Lu, Mei-Sze Chua, Samuel K. So
Oncotarget.2015; 6(39): 41722.     CrossRef